Fragment screening reveals starting points for rational design of galactokinase 1 inhibitors to treat classic galactosemia - Mackinnon, SR; Krojer, T; Foster, WR; Diaz-Saez, L; Tang, M; Huber, KVM; von Delft, F; Lai, K; Brennan, PE; Arruda Bezerra, G; Yue, WW (ACS Chemical Biology, 2021)